These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8573686)

  • 1. Pharmacokinetic parameters of antipyrine in dog after hepatectomy.
    Galtier M; Briand D; Pinguet F; Gomeni R; Fabre D; Bressolle F
    Biopharm Drug Dispos; 1995 Nov; 16(8):669-84. PubMed ID: 8573686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative disposition of pharmacologic markers for cytochrome P-450 mediated metabolism, glomerular filtration rate, and extracellular and total body fluid volume of Greyhound and Beagle dogs.
    KuKanich B; Coetzee JF; Gehring R; Hubin M
    J Vet Pharmacol Ther; 2007 Aug; 30(4):314-9. PubMed ID: 17610404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of antipyrine in calves after intravenous and oral administration.
    Janus K; Muszczynski Z; Suszycka J
    J Vet Pharmacol Ther; 1996 Oct; 19(5):408-10. PubMed ID: 8905578
    [No Abstract]   [Full Text] [Related]  

  • 4. Accuracy of the one-sample method for determination of antipyrine clearance in elderly subjects.
    Jorquera F; Almar MM; González-Sastre M; Suarez I; González-Gallego J
    J Pharm Biomed Anal; 1996 Oct; 15(1):7-11. PubMed ID: 8895071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of short-term water deprivation on antipyrine disposition in calves.
    Janus K; Muszczynski Z; Suszycka J
    Res Vet Sci; 1997; 63(1):1-3. PubMed ID: 9368948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The suppressive effects of lipopolysaccharide-induced acute phase response on hepatic cytochrome P450-dependent drug metabolism in rabbits.
    Saitoh T; Kokue E; Shimoda M
    J Vet Pharmacol Ther; 1999 Apr; 22(2):87-95. PubMed ID: 10372593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of antipyrine kinetics from saliva or plasma: influence of age.
    Jorquera F; Almar MM; Jimeno A; González-Sastre M; González-Gallego J
    J Pharm Biomed Anal; 1995 Aug; 13(9):1141-5. PubMed ID: 8573640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in pharmacokinetics of antipyrine in a simulated weightlessness rat model.
    Wei B; Abobo CV; Ma J; Liang D
    Aviat Space Environ Med; 2012 Jan; 83(1):8-13. PubMed ID: 22272510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of water deprivation on the pharmacokinetics of antipyrine and sulphadimidine following intravenous administration in Nubian goats.
    Elsheikh HA; Osman IA; Abdullah AS
    Vet Res Commun; 1997 Nov; 21(8):587-97. PubMed ID: 9444081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of patients with impaired hepatic drug metabolism using a limited sampling procedure for estimation of phenazone (antipyrine) pharmacokinetic parameters.
    Fabre D; Bressolle F; Goméni R; Bouvet O; Dubois A; Raffanel C; Gris JC; Galtier M
    Clin Pharmacokinet; 1993 Apr; 24(4):333-43. PubMed ID: 8491059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simplified approaches to the determination of antipyrine pharmacokinetic parameters.
    Scavone JM; Greenblatt DJ; Blyden GT; Harmatz JS; Graziano PJ
    Br J Clin Pharmacol; 1988 Jun; 25(6):695-9. PubMed ID: 3203041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One sample antipyrine clearance after 90% partial hepatectomy in the rat.
    Poulsen HE
    Liver; 1985 Aug; 5(4):200-4. PubMed ID: 4058272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of sex on antipyrine metabolism in cattle at different ages.
    Janus K; Antoszek J
    J Vet Pharmacol Ther; 1999 Jun; 22(3):163-9. PubMed ID: 10447826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipyrine and caffeine dispositions in clinically normal dogs and dogs with progressive liver disease.
    Boothe DM; Cullen JM; Calvin JA; Jenkins WL; Brown SA; Green RA; Corrier DE
    Am J Vet Res; 1994 Feb; 55(2):254-61. PubMed ID: 8172417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of hepatic enzyme induction in prostate cancer patients receiving 'Casodex' (bicalutamide).
    Kaisary A; Klarskov P; McKillop D
    Anticancer Drugs; 1996 Jan; 7(1):54-9. PubMed ID: 8742099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of continuous interleukin-2 administration via the portal vein on liver regeneration following partial hepatectomy in rats.
    Wadamori K; Oka M; Tokuda N; Fujikura Y; Hazama S; Fukumoto T; Suzuki T
    Hepatology; 1996 Jun; 23(6):1578-83. PubMed ID: 8675180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the protective effects of Schisandra chinensis on Phase I drug metabolism using a CCl4 intoxication model.
    Zhu M; Lin KF; Yeung RY; Li RC
    J Ethnopharmacol; 1999 Oct; 67(1):61-8. PubMed ID: 10616961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous pharmacokinetics of penicillin G and antipyrine in ostriches (Struthio camelus) and emus (Dromaius novaehollandiae).
    Clarke CR; Kocan AA; Webb AI; Wang Z; Cudd LA
    J Zoo Wildl Med; 2001 Mar; 32(1):74-7. PubMed ID: 12790398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of cimetidine on antipyrine metabolism in calves.
    Janus K; Suszycka J
    J Vet Pharmacol Ther; 1997 Feb; 20(1):73-6. PubMed ID: 9049953
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of atorvastatin, an HMG-CoA reductase inhibitor, on hepatic oxidative metabolism of antipyrine.
    Yang BB; Hounslow NJ; Sedman AJ; Forgue ST
    J Clin Pharmacol; 1996 Apr; 36(4):356-60. PubMed ID: 8728350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.